CMS increases final pricing determination for Oncotype DX(R) breast cancer test
The CMS issued updated pricing determinations for the Clinical Laboratory Fee Schedule including a payment rate of $3,416 for the Oncotype DX® breast cancer test. This means the payment rate for the Oncotype DX breast cancer test will remain at the current contracted rate of $3,416 through 2016. October 07, 2015